What are the Challenges in Developing Biomedical Devices for Cancer?
Despite the advancements, there are challenges. Ensuring the safety and efficacy of new devices through rigorous clinical trials is time-consuming and expensive. Regulatory approvals from bodies like the FDA or EMA are stringent. Additionally, integrating new technologies into existing healthcare systems and ensuring accessibility and affordability for patients remain significant hurdles.
